These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 22110541)

  • 21. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
    Murphy G; Lisnevskaia L; Isenberg D
    Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
    Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenetic significance of autoantibodies].
    Genth E
    Internist (Berl); 1999 Sep; 40(9):914-21. PubMed ID: 10506330
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigen-specific immunotherapies in rheumatic diseases.
    Pozsgay J; Szekanecz Z; Sármay G
    Nat Rev Rheumatol; 2017 Sep; 13(9):525-537. PubMed ID: 28701761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cells: depletion or functional modulation in rheumatic diseases.
    Dörner T; Lipsky PE
    Curr Opin Rheumatol; 2014 Mar; 26(2):228-36. PubMed ID: 24126901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on epigenetic-based immune intervention for rheumatic diseases.
    Gray SG
    Arthritis Res Ther; 2013 Mar; 15(2):207. PubMed ID: 23510070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyautoimmunity in rheumatological conditions.
    Matusiewicz A; Stróżyńska-Byrska J; Olesińska M
    Int J Rheum Dis; 2019 Mar; 22(3):386-391. PubMed ID: 30548416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infection and autoimmunity. Progress in diagnosis and therapy].
    Gross WL
    Internist (Berl); 2003 Feb; 44(2):145. PubMed ID: 12674733
    [No Abstract]   [Full Text] [Related]  

  • 29. The interferon signature in autoimmune diseases.
    Rönnblom L; Eloranta ML
    Curr Opin Rheumatol; 2013 Mar; 25(2):248-53. PubMed ID: 23249830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
    Giacomelli R; Afeltra A; Alunno A; Baldini C; Bartoloni-Bocci E; Berardicurti O; Carubbi F; Cauli A; Cervera R; Ciccia F; Cipriani P; Conti F; De Vita S; Di Benedetto P; Doria A; Drosos AA; Favalli EG; Gandolfo S; Gatto M; Grembiale RD; Liakouli V; Lories R; Lubrano E; Lunardi C; Margiotta DPE; Massaro L; Meroni P; Minniti A; Navarini L; Pendolino M; Perosa F; Pers JO; Prete M; Priori R; Puppo F; Quartuccio L; Ruffatti A; Ruscitti P; Russo B; Sarzi-Puttini P; Shoenfeld Y; Somarakis GA; Spinelli FR; Tinazzi E; Triolo G; Ursini F; Valentini G; Valesini G; Vettori S; Vitali C; Tzioufas AG
    Autoimmun Rev; 2017 Sep; 16(9):911-924. PubMed ID: 28705780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatic autoimmune diseases: proposed elimination of autoreactive B-cells with magnetic nanoparticle-linked antigens.
    Bollmann FM
    Med Hypotheses; 2012 Apr; 78(4):479-81. PubMed ID: 22285628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.
    Eloranta ML; Alm GV; Rönnblom L
    Arthritis Rheum; 2013 Apr; 65(4):853-63. PubMed ID: 23280551
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding autoimmune disease: new targets for drug discovery.
    Balagué C; Kunkel SL; Godessart N
    Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of interleukin-4 in rheumatic diseases.
    Dong C; Fu T; Ji J; Li Z; Gu Z
    Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):747-754. PubMed ID: 29655253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B cell conducts the lymphocyte orchestra.
    Youinou P
    J Autoimmun; 2007; 28(2-3):143-51. PubMed ID: 17363215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response.
    Peron JP; de Oliveira AP; Rizzo LV
    Autoimmun Rev; 2009 Sep; 9(1):1-4. PubMed ID: 19224711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
    Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologics in the treatment of skin and rheumatologic diseases.
    Kahlenberg JM; Billi AC; Eyerich K; Gudjonsson JE
    J Allergy Clin Immunol; 2020 Apr; 145(4):1138-1141. PubMed ID: 32112793
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autoimmune Rheumatic Diseases - Problems of Immunopathology and Personalized Treatment].
    Nasonov EL; Aleksandrova EN; Novikov AA
    Vestn Ross Akad Med Nauk; 2015; (2):169-82. PubMed ID: 26234089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting dendritic cell function during systemic autoimmunity to restore tolerance.
    Mackern-Oberti JP; Vega F; Llanos C; Bueno SM; Kalergis AM
    Int J Mol Sci; 2014 Sep; 15(9):16381-417. PubMed ID: 25229821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.